ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
Official Title  Antidepressant Adherence Among Hispanics: A Motivational Interviewing Approach
Brief Summary

This study will determine the effectiveness of motivational interviewing in improving antidepressant medication adherence among Hispanics.

Detailed Description

Depression is a serious mental illness characterized by symptoms that can interfere with a person's ability to work, study, eat, sleep, and enjoy activities that were once pleasurable. Studies have shown that people of Hispanic descent tend to underutilize mental health care services. Additionally, Hispanics have demonstrated lower compliance and completion rates for antidepressant treatment. This may be due to low socioeconomic status, lack of family financial support, and inadequate communication with mental health care providers. Motivational interviewing is a goal-oriented type of therapy that focuses on eliciting behavior change by identifying and mobilizing a person's values. This study will determine the effectiveness of culturally sensitive motivational interviewing in improving antidepressant medication adherence in Hispanics.

Participants in this 6-month, open-label study will be randomly assigned to receive either motivational interviewing in addition to their antidepressant therapy or treatment as usual. All participants will first attend a 45-minute screening visit, which will include questionnaires and an interview about psychiatric symptoms, medication attitudes, and medication adherence behavior. Participants will also receive an electronic medication container that will record how consistently medication is taken. Participants assigned to motivational interviewing will then attend two 1-hour sessions of motivational interviewing over 2 consecutive weeks, followed by a third session 8 weeks later. The group assigned to treatment as usual will not partake in motivational interviewing, but will continue to receive their normal care. All participants will return to the study site for follow-up assessments, which will include measures of antidepressant adherence, at Months 2 and 5.

Study Phase Phase I
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Medication adherence, as measured by electronic pill container [ Time Frame: Measured immediately post-treatment and at Months 2 and 5 follow-ups ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Treatment retention [ Time Frame: Measured at Month 6 ] [ Designated as safety issue: No ]
Depression [ Time Frame: Measured at Month 6 ] [ Designated as safety issue: No ]
Medication attitudes [ Time Frame: Measured at Month 6 ] [ Designated as safety issue: No ]
Condition  Depression
Intervention  Behavioral: Motivational interviewing
Behavioral: Treatment as usual
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  90
Start Date  April 2006
Completion Date August 2010
Eligibility Criteria 

Inclusion Criteria:

  • Self-identifies as Hispanic
  • DSM-IV diagnosis of any unipolar depressive disorder (i.e., MDD, dysthymia, or depressive disorder not otherwise specified)
  • Currently taking antidepressant medication

Exclusion Criteria:

  • Clinically significant suicidal ideation
  • DSM-IV diagnosis of any substance-related disorder, bipolar disorder, or psychotic disorder/features within 12 months prior to study entry
  • Unstable general medical condition
Gender Both
Ages 18 Years to 65 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Alejandro Interian, PhD     732-235-3959     interial@umdnj.edu    
Contact: Igda Martinez, PsyM     732-235-5908     martini2@umdnj.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00356304
Organization ID K23 MH74860
Secondary IDs †† DSIR 8K-RT
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Alejandro Interian, PhD     University of Medicine and Dentistry New Jersey    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date February 2008
First Received Date  July 21, 2006
Last Updated Date February 13, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers